Physician profile
Richard Luck
NPI 1588664379
$1,005.04
in general payments reported to CMS, 2019-2025
12 companies · $196 in 2025
The $196 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.78 · 2020: $37.25 · 2021: $42.89 · 2022: $12.36 · 2023: $242 · 2024: $447 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $886.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $885.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $250.00 | 2023-2024 | Miebo, Xiidra |
| Astellas Pharma US INC | $152.19 | 2024 | Izervay |
| Oyster Point Pharma, INC. | $149.91 | 2022-2025 | Tyrvaya |
| Amgen INC. | $125.00 | 2024 | Tepezza |
| Glaukos Corporation | $86.88 | 2025 | Idosetr |
| Alcon Vision LLC | $75.51 | 2019-2024 | Clareon |
| Sun Pharmaceutical Industries INC. | $42.89 | 2021 | |
| Harrow Eye, LLC | $38.84 | 2025 | Iheezo |
| Genentech USA, INC. | $25.71 | 2025 | Vabysmo |
| Abbvie INC. | $24.41 | 2025 | |
| Mallinckrodt Hospital Products INC. | $20.62 | 2024 | Acthar |
| Allergan, INC. | $13.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Luck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.